Pu-Ning Chiang is an Associate on the Impact Investment Team at GEM. In this role, Pu-Ning is responsible for underwriting the impact of the firm’s investments, performing market research on impact investing, and developing materials in support of team and firm leadership’s understanding of key impact issues. Prior to joining GEM in 2022, she worked as a Venture Capital Analyst at both Fresenius Medical Care Ventures and Trans-Pacific Technology Fund. Prior to that, she was an Associate Brand Manager at MilliporeSigma, Merck KGaA. Pu-Ning received a B.S. in Neuroscience and an M.A. in Biotechnology from Brown University.
Let’s start a conversation about how we can help.